Nothing Special   »   [go: up one dir, main page]

BR9803243A - Aplicação de inibidores do trocador de sódio-hidrogênio para a preparação de um medicamento para o tratamento de distúrbios causados por protozoários. - Google Patents

Aplicação de inibidores do trocador de sódio-hidrogênio para a preparação de um medicamento para o tratamento de distúrbios causados por protozoários.

Info

Publication number
BR9803243A
BR9803243A BR9803243A BR9803243A BR9803243A BR 9803243 A BR9803243 A BR 9803243A BR 9803243 A BR9803243 A BR 9803243A BR 9803243 A BR9803243 A BR 9803243A BR 9803243 A BR9803243 A BR 9803243A
Authority
BR
Brazil
Prior art keywords
carbon atoms
pathogen
malaria
preparation
treatment
Prior art date
Application number
BR9803243A
Other languages
English (en)
Inventor
Hans Jochen Dr Lang
Michael Dr Lanzer
Jochen Wiesner
Cecilia Dr Sanchez
Stefan Dr Wuensch
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of BR9803243A publication Critical patent/BR9803243A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

CAUSADOS POR PROTOZOáRIOS". <D> Inibidores do trocm combinação com outras classes de substâncias atim, de doenças causadas por protozoários patogênicos intracelularmente das classes Apicomplexa e Zoomastigophorea, especialmente tripanosomoses, plasmódios (causadores e malaria), leishmânias, babésias e teilerias, Cryptosporidiidae, Sarcocystidae, amspecialmente adequados, de preferência, para a preparação de um medicamento para o tratamento de malária tropical, de malária tertiana, de malária quartana, bem como da toxoplasmose, de coccidioses, d, da doenças de Chagas e de leishmanioses cutânea e visceral, bem como de outras formas de leishmanioses; e também para a preparação de um medicamento para o tratamento de animais que foram infestados por protozoários patogênicos animais, tais como pe do Texas do gado e búfalos, Bebesia bovis, o patógeno da babesiose bovina européia e bebesioses em cães, gatos e ovelhas sarcocistidae, o patógeno de sarcostideoses em ovelhas, gado e porcos, Cryptosporididae, o patógeno de crisptosporidiose no gado e pássaros, coccidia, o patógeno da coccidiose decialmente de galinhas de perus. Sendo que a fenila é não substituída ou é substituída por 1 - 3 substituintes escolhidos do grupo constituído de F, CI,CF3, metila, metóxi e NR (11)R(12); R(11) e R (a com 1,2,3 o 4 átomos de carbono ou perfluoralquila com 1,2,3o4 átomos de carbono; R(6) e R(7) independentes entre si, respresentam hidrogênio, F,CI, Br,I, CN, alquila com 1,2,3,4,5,6,77 ou 8 átomos de carbono, perfluoralquila com 1,2,3,4,5,6,7 ou 88 átomos de carbono ou fenila, que é não substituído de F,CI,CF3, metila, metóxi e NR (14)R(15); R(lquila com 1,2,3 ou 4 átomos de carbono ou perfluoalquila com 1,2,3 ou 4 átomos de carbono; e seus toleráveis farmaceuticamente.
BR9803243A 1997-08-28 1998-08-27 Aplicação de inibidores do trocador de sódio-hidrogênio para a preparação de um medicamento para o tratamento de distúrbios causados por protozoários. BR9803243A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19737463A DE19737463A1 (de) 1997-08-28 1997-08-28 Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden

Publications (1)

Publication Number Publication Date
BR9803243A true BR9803243A (pt) 2000-03-21

Family

ID=7840411

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9803243A BR9803243A (pt) 1997-08-28 1998-08-27 Aplicação de inibidores do trocador de sódio-hidrogênio para a preparação de um medicamento para o tratamento de distúrbios causados por protozoários.

Country Status (26)

Country Link
US (1) US6114393A (pt)
EP (1) EP0901788A3 (pt)
JP (1) JPH11171792A (pt)
KR (1) KR100567144B1 (pt)
CN (1) CN1244322C (pt)
AR (1) AR013949A1 (pt)
AU (1) AU738599B2 (pt)
BR (1) BR9803243A (pt)
CA (1) CA2246407A1 (pt)
CZ (1) CZ296815B6 (pt)
DE (1) DE19737463A1 (pt)
HK (1) HK1018589A1 (pt)
HR (1) HRP980468A2 (pt)
HU (1) HU225583B1 (pt)
ID (1) ID20794A (pt)
IL (1) IL125946A0 (pt)
MY (1) MY137406A (pt)
NO (1) NO320368B1 (pt)
NZ (1) NZ331566A (pt)
PL (1) PL191267B1 (pt)
RU (1) RU2225726C2 (pt)
SG (1) SG74074A1 (pt)
SK (1) SK285457B6 (pt)
TR (1) TR199801669A2 (pt)
TW (1) TW592690B (pt)
ZA (1) ZA987781B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
CZ20022046A3 (cs) * 1999-12-23 2002-11-13 Pfizer Products Inc. Hydrogelem hnaná dávková forma účinné sloľky
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
HUE056766T2 (hu) * 2017-07-04 2022-03-28 Sanofi Sa Etinil-vegyületek, ezek elõállítása és terápiás alkalmazása malária kezelésére

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336871A (en) * 1970-01-02 1973-11-14 Wellcome Found Method for preparing biologically active substituted amidines
US4032655A (en) * 1974-05-15 1977-06-28 Bayer Aktiengesellschaft Phenylguanidines useful as anthelmintic agents
US4088780A (en) * 1974-05-15 1978-05-09 Bayer Aktiengesellschaft Substituted phenylguanidines and processes for their preparation and use
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
IN172842B (pt) * 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
JPH07503944A (ja) * 1991-11-22 1995-04-27 イエダ　リサーチ　アンド　デベロツプメント　カンパニー　リミテツド Ａｒｇ−ｇｌｙ−ａｓｐ配列の非ペプチド代替物およびそれらからなる医薬組成物
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19502644A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
EP1420027A3 (en) * 1995-06-07 2012-01-04 Genaera Corporation Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
NO983943L (no) 1999-03-01
CZ272998A3 (cs) 1999-03-17
SK285457B6 (sk) 2007-02-01
CZ296815B6 (cs) 2006-06-14
HU225583B1 (en) 2007-03-28
PL328265A1 (en) 1999-03-01
AU738599B2 (en) 2001-09-20
AU8189498A (en) 1999-03-11
IL125946A0 (en) 1999-04-11
HU9801925D0 (en) 1998-10-28
TR199801669A3 (tr) 1999-03-22
MY137406A (en) 2009-01-30
NO983943D0 (no) 1998-08-27
NZ331566A (en) 2001-03-30
ZA987781B (en) 1999-05-27
SG74074A1 (en) 2000-07-18
CA2246407A1 (en) 1999-02-28
HRP980468A2 (en) 1999-06-30
ID20794A (id) 1999-03-04
EP0901788A2 (de) 1999-03-17
HUP9801925A3 (en) 2004-11-29
PL191267B1 (pl) 2006-04-28
TW592690B (en) 2004-06-21
RU2225726C2 (ru) 2004-03-20
KR100567144B1 (ko) 2006-11-30
US6114393A (en) 2000-09-05
HUP9801925A1 (hu) 2000-02-28
TR199801669A2 (xx) 1999-03-22
SK117498A3 (en) 1999-03-12
KR19990023905A (ko) 1999-03-25
AR013949A1 (es) 2001-01-31
CN1244322C (zh) 2006-03-08
HK1018589A1 (en) 1999-12-30
CN1209994A (zh) 1999-03-10
EP0901788A3 (de) 2004-01-02
JPH11171792A (ja) 1999-06-29
DE19737463A1 (de) 1999-03-04
NO320368B1 (no) 2005-11-28

Similar Documents

Publication Publication Date Title
Meagher et al. On the origin of brucellosis in bison of Yellowstone National Park: a review
Hocking et al. Effects of non-steroidal anti-inflammatory drugs on pain-related behaviour in a model of articular pain in the domestic fowl
Ipema et al. Long-term access to live black soldier fly larvae (Hermetia illucens) stimulates activity and reduces fearfulness of broilers, without affecting health
DE69820265D1 (de) Für den vogelembryo geeignete multivalente impfstoffe
BR9808417A (pt) Produto alimentìcio para animais de estimação
Dipeolu et al. Residues of streptomycin antibiotic in meat sold for human consumption in some states of SW Nigeria
ATE72980T1 (de) Anthelmintische quaternaere alkyl-acyl-hydrazone, verfahren zur verwendung und zusammensetzungen.
BR9803243A (pt) Aplicação de inibidores do trocador de sódio-hidrogênio para a preparação de um medicamento para o tratamento de distúrbios causados por protozoários.
ES8801544A1 (es) Procedimiento para preparar piridinil acilhidrazonas
Dreyer et al. Predation of livestock ticks by chickens as a tick-control method in a resource-poor urban environment
Yoder et al. Comparison of nicarbazin absorption in chickens, mallards, and Canada geese
Metz et al. Behavioural criteria for the design of housing systems for cattle
Pollock et al. Sedative effects of medetomidine in pigeons (Columba livia)
Luescher Hyperkinesis in dogs: six case reports
Sainsbury et al. Health and welfare of rehabilitated juvenile hedgehogs (Erinaceus europaeus) before and after release into the wild
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
ATE77237T1 (de) Anthelmintische acylhydrazone, verfahren zur verwendung und zusammensetzungen.
Hough Effects of gamma radiation on codling moth eggs
UA79583C2 (en) Use of combined 5-ht1a agonists and serotonin reuptake inhibitors
ATE71839T1 (de) Anthelmintische acylhydrazone verfahren zur verwendung und zusammensetzungen.
BR0112227A (pt) Método de administrar e comercializar animais de criação baseado nos perfis genéticos
CN213130082U (zh) 一种畜牧兽医治疗用保定架
AR041771A1 (es) Metodos para reducir los indices de mortalidad de aves de corral
Ghazaei Evaluation of the effect of antihelminthic agents albendazole, fenbendazole and praziquantel in treatment of coenurosis disease in sheep
Welch et al. Techniques for rearing moose calves with resulting weight gains and survival

Legal Events

Date Code Title Description
TC Change of name
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.